Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia

References

• Paschka P, Marcucci G, Ruppert AS, . Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol 2006;24:3904–3911.
   PubMed Web of Science ®Google Scholar
• Fuster O, Barragan E, Bolufer P, . Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis. J Mol Diagn 2009;11:458–463.
   PubMed Web of Science ®Google Scholar
• Schnittger S, Kohl TM, Haferlach T, . KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival. Blood 2006;107:1791–1799.
   PubMed Web of Science ®Google Scholar
• Boissel N, Leroy H, Brethon B, . Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia 2006;20:965–970.
   PubMed Web of Science ®Google Scholar
• Park SH, Chi HS, Min SK, . Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia. Leuk Res 2011;35:1376–1383.
   PubMed Web of Science ®Google Scholar
• Castilla LH, Garrett L, Adya N, . The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet 1999;23:144–146.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhou L, Miyamoto T, . AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001; 98:10398–10403.
   PubMed Web of Science ®Google Scholar
• Cairoli R, Beghini A, Grillo G, . Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 2006;107:3463–3468.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, ., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 54–63, 109–147.
   Google Scholar
• Kristensen T, Vestergaard H, Moller MB. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn 2011;13:180–188.
   PubMed Web of Science ®Google Scholar
• Valent P, Akin C, Escribano L, . Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37: 435–453.
   PubMed Web of Science ®Google Scholar
• Fritsche-Polanz R, Fritz M, Huber A, . High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V. Mol Oncol 2010; 4:335–346.
   PubMed Web of Science ®Google Scholar
• Pullarkat ST, Pullarkat V, Kroft SH, . Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia. J Hematop 2009;2:27–33.
   PubMedGoogle Scholar
• Care RS, Valk PJ, Goodeve AC, . Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias. Br J Haematol 2003;121:775–777.
   PubMed Web of Science ®Google Scholar
• Beghini A, Peterlongo P, Ripamonti CB, . C-kit mutations in core binding factor leukemias. Blood 2000;95:726–727.
   PubMed Web of Science ®Google Scholar
• Ustun C, Corless CL, Savage N, . Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V. Leuk Res 2009;33:735–741.
   PubMed Web of Science ®Google Scholar
• Preiss BS, Kerndrup GB, Schmidt KG, . Cytogenetic findings in adult de novo acute myeloid leukaemia. A population-based study of 303/337 patients. Br J Haematol 2003;123:219–234.
   PubMed Web of Science ®Google Scholar
• Preiss BS, Bergmann OJ, Friis LS, . Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML. Cancer Genet Cytogenet 2010;202:108–122.
   PubMed Web of Science ®Google Scholar
• Yunis JJ. High-resolution of human chromosomes. Science 1976;191:1268–1270.
   PubMed Web of Science ®Google Scholar
• Schaffer LG, Slovak ML, Campbell LJ, editors. ISCN: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2009.
   Google Scholar
• Gabert J, Beillard E, van der Velden VHJ, . Standardization and quality control studies of “real-time” quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003;17:2318–2357.
   PubMed Web of Science ®Google Scholar
• Beillard E, Pallisgaard N, van der Velden VHJ, . Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using “real-time” quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe Against Cancer program. Leukemia 2003;17:2474–2486.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
   PubMed Web of Science ®Google Scholar
• Bernd HW, Sotlar K, Lorenzen J, . Acute myeloid leukaemia with t(8;21) associated with “occult” mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 2004;57:324–328.
   PubMed Web of Science ®Google Scholar
• Pullarkat VA, Bueso-Ramos C, Lai R, . Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 2003;73:12–17.
   PubMed Web of Science ®Google Scholar
• Wakita S, Yamaguchi H, Miyake K, . Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia. Leukemia 2011;25: 1423–1432.
   PubMed Web of Science ®Google Scholar
• Wang YY, Zhou GB, Yin T, . AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA 2005;102: 1104–1109.
   PubMed Web of Science ®Google Scholar
• Sperr WR, Walchshofer S, Horny HP, . Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val. Br J Haematol 1998;103:740–749.
   PubMed Web of Science ®Google Scholar
• Nagai S, Ichikawa M, Takahashi T, . The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Exp Hematol 2007;35:1747–1752.
   PubMed Web of Science ®Google Scholar
• Pullarkat V, Bedell V, Kim Y, . Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 2007;31:261–265.
   PubMed Web of Science ®Google Scholar
• Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002;3:179–198.
   PubMed Web of Science ®Google Scholar